ReviewFirst-line immune-checkpoint inhibitor combination therapy for chemotherapy-eligible patients with metastatic urothelial carcinoma: A systematic review and meta-analysis
Under a Creative Commons license
open access
Keywords
Urothelial carcinoma
Meta-analysis
Immune-checkpoint inhibitor
Programmed death-ligand 1
Cited by (0)
© 2021 The Authors. Published by Elsevier Ltd.